Skip to main content
SpringerLink
Log in

Consider possible changes in the pharmacokinetic properties of antibacterials when treating the critically ill

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet 2005; 44(10): 1009–34

    Article  PubMed  CAS  Google Scholar 

  2. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001; 120(6): 2059–93

    Article  PubMed  CAS  Google Scholar 

  3. Hyatt JM, Schentag JJ. Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance. Infect Control Hosp Epidemiol 2000; 21(1 Suppl.): S18–21

    Article  PubMed  CAS  Google Scholar 

  4. Pea F, Furlanut M. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions. Clin Pharmacokinet 2001; 40(11): 833–68

    Article  PubMed  CAS  Google Scholar 

  5. Wada DR, Drover DR, Lemmens HJ. Determination of the distribution volume that can be used to calculate the intravenous loading dose. Clin Pharmacokinet 1998; 35(1): 1–7

    Article  PubMed  CAS  Google Scholar 

  6. De Paepe P, Belpaire FM, Buylaert WA. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. Clin Pharmacokinet 2002; 41(14): 1135–51

    Article  PubMed  Google Scholar 

  7. Pinder M, Bellomo R, Lipman J. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 2002; 30(2): 134–44

    PubMed  CAS  Google Scholar 

  8. Eid AA, Keddissi JI, Kinasewitz GT. Hypoalbuminemia as a cause of pleural effusions. Chest 1999; 115(4): 1066–9

    Article  PubMed  CAS  Google Scholar 

  9. Henriksen JH, Kiszka-Kanowitz M, Bendtsen F. Review article: volume expansion in patients with cirrhosis. Aliment Pharmacol Ther 2002; 16Suppl. 5: 12–23

    Article  PubMed  Google Scholar 

  10. Westphal JF, Brogard JM. Clinical pharmacokinetics of newer antibacterial agents in liver disease. Clin Pharmacokinet 1993; 24(1): 46–58

    Article  PubMed  CAS  Google Scholar 

  11. Rowland M. Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet 1990; 18(3): 184–209

    Article  PubMed  CAS  Google Scholar 

  12. Jaehde U, Sorgel F. Clinical pharmacokinetics in patients with burns. Clin Pharmacokinet 1995; 29(1): 15–28

    Article  PubMed  CAS  Google Scholar 

  13. King CH, Creger RJ, Ellner JJ. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother 1985; 27(3): 285–90

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Consider possible changes in the pharmacokinetic properties of antibacterials when treating the critically ill. Drugs Ther. Perspect 22, 21–23 (2006). https://doi.org/10.2165/00042310-200622090-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622090-00007

Search

Navigation